Invenra is attending the 17th Annual World Bispecific Summit in Boston.
Public source
Publisher name
Public post
In less than two weeks, we’re headed to Boston for the 17th Annual World Bispecific Summit! As lead partner, our team will be sharing the latest advances in multispecifi…
Company
Invenra
- Industry
- Biotechnology Research
- Location
- Madison, US
- Company size
- 51–200 employees
About Invenra
Invenra offers flexible partnering options to meet diverse antibody discovery needs, from rapid, focused bispecific antibody discovery to comprehensive, collaborative development partnerships. Our new rapid bispecific discovery service, powered by the B-Body® Bispecific Platform, identifies bispecific lead panels within four months through functional screening of over 250 bispecific combinations, using mAbs derived from 90 parallel discovery screens. For those seeking a strategic, partnered approach, Invenra provides tailored support across all stages of discovery, from custom antigen design and assay development to in-depth biological analysis. This dual offering allows us to address a broad spectrum of objectives, from expedited project timelines for focused discovery services to fully integrated solutions for collaborative development partnerships.
See moreLatest activity
Latest activity from Invenra
6 signals
Presence & Recognition
Invenra featured Julie Ragland and her artwork as part of the 52 Views of Cancer initiative.
Presence & Recognition
Invenra is presenting a presentation from Andrew Garfoot, Ph.D., on bi- and trispecific antibody approaches expanding target coverage and driving durable tumor control in next-generation ADCs.
Presence & Recognition
Invenra is presenting a poster highlighting its B-Body and T-Body platforms for rapid and comprehensive screening for multispecific ADC development.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
TriLink BioTechnologies, part of Maravai LifeSciences
TriLink BioTechnologies, part of Maravai LifeSciences is attending the 11th Annual CAR-TCR Summit Series in Boston.
Presence & Recognition
Biointron
Biointron is hosting a 1-on-1 meeting in Boston on September 15-17, 2026, at The Westin Boston Seaport, featuring a conversation on advances in bispecific antibody development.
Presence & Recognition
Biocytogen
Biocytogen is attending the Oncology & Immunology Innovation Partnering & Licensing Summit in Boston from September 9 to 10, 2026.
Presence & Recognition
Inductive Bio
Inductive Bio is hosting the Discovery on Target 2026 conference in Boston on September 28 to October 1, featuring a speaking slot and a booth.
Presence & Recognition
BioLegend